Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Article in English | WPRIM | ID: wpr-19480

ABSTRACT

In order to observe the effects of serum albumin and fibrinogen on biophysical surface properties and the morphology of pulmonary surfactant in vitro, we measured the surface adsorption rate, dynamic minimum and maximum surface tension (min-, max-ST) by Pulsating Bubble Surfactometer, and demonstrated ultrastructures on a series of mixtures with varying concentrations of albumin or fibrinogen and Surfactant-TA. The albumin and fibrinogen significantly inhibited the adsorption rate and ST-lowering properties of surfactant through increasing STs of adsorption rate, min-ST, and max-ST. The characteristic morphology of the Surfactant-TA changed from lamellar rod-like structure with open ends into spherical structures with loss of their open ends by mixing with albumin or fibrinogen. These inhibitory effects of albumin and fibrinogen on surface properties of surfactant were dependent upon the increasing concentration of albumin or fibrinogen. We concluded that albumin and fibrinogen significantly altered surfactant function and its ultrastructural morphology in vitro. These findings support the concept that albumin and fibrinogen-induced surfactant dysfunction may play an important role in the pathophysiology of adult respiratory distress syndrome, and this adverse effect of albumin and fibrinogen on surfactant might be overcome by administration of large doses of exogenous surfactant.


Subject(s)
Adsorption , Animals , Cattle , Fibrinogen/pharmacology , Humans , Pulmonary Surfactants/ultrastructure , Pulmonary Surfactants/drug effects , Serum Albumin, Bovine/pharmacology , Surface Properties
2.
Rev. Inst. Nac. Enfermedades Respir ; 8(2): 150-8, abr.-jun. 1995. ilus, tab
Article in Spanish | LILACS | ID: lil-158954

ABSTRACT

La ausencia de surfactantes pulmonares trae como consecuencia el incremento de la tensión superficial a lo largo del epitelio alveolar, provocando un colapso alveolar y la lisis de las células epiteliales. Este proceso culmina con la aparición de un síndrome de insuficiencia respiratoria, que es la causa principal de morbimortalidad en niños prematuros. Recientemente, la aplicación de mezclas de agentes surfactantes con fines terapéuticos ha constituido un gran apoyo para la terapia respiratoria, ya que permite una evolución más rápida de los niños que padecen este síndrome. Por todo esto, resulta de gran importancia el conocimiento más detallado de la función, el metabolismo y la regulación de la expresión genética de las proteíinas surfactantes, para el diseño de nuevas y mejores estrategias terapéuticas para combatir este síndrome


Subject(s)
1,2-Dipalmitoylphosphatidylcholine/biosynthesis , 1,2-Dipalmitoylphosphatidylcholine/chemistry , Phospholipids/biosynthesis , Phospholipids/chemistry , Lectins/chemistry , Pulmonary Alveoli/drug effects , Pulmonary Alveoli/physiology , Pulmonary Surfactants/chemistry , Pulmonary Surfactants/genetics , Pulmonary Surfactants/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL